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a Brain and Mind Research, Central European Institute of Technology, Masaryk University, 5 Kamenice, Brno 62500, Czech Republic 
b RECETOX, Faculty of Science, Masaryk University, 5 Kamenice, Brno 62500, Czech Republic 
c Faculty of Informatics, Masaryk University, 68A Botanicka, Brno 60200, Czech Republic 
d Institute for Clinical Evaluative Sciences, 2075 Bayview Avenue, Toronto, ON M4N3M5, Canada 
e Hospital for Sick Children, University of Toronto, 686 Bay Street, Toronto, ON M5G0A4, Canada 
f Molecular Medicine, Central European Institute of Technology, Masaryk University, 5 Kamenice, Brno 62500, Czech Republic 
g Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital, 150 Kilgour Rd, East York, Toronto, ON M4G1R8, Canada 
h Departments of Psychology and Psychiatry, University of Toronto, 100 St. George Street, Toronto, ON M5S3G3, Canada   
A R T I C L E  I N F O   
Keywords: 
DNA methylation age 
Anxiety 
Gray matter volume 
Frontal lobe 
Sex differences 
A B S T R A C T   
DNA methylation changes consistently throughout life and age-dependent alterations in DNA methylation can be 
used to estimate one’s epigenetic age. Post-mortem studies revealed higher epigenetic age in brains of patients 
with major depressive disorder, as compared with controls. Since MDD is highly correlated with anxiety, we 
hypothesized that symptoms of anxiety, as well as lower volume of grey matter (GM) in depression-related 
cortical regions, will be associated with faster epigenetic clock in a community-based sample of young adults. 
Participants included 88 young adults (53% men; 23–24 years of age) from the European Longitudinal Study of 
Pregnancy and Childhood (ELSPAC) who participated in its neuroimaging follow-up and provided saliva samples 
for epigenetic analysis. Epigenetic age was calculated according to Horvath (Horvath, 2013). Women had slower 
epigenetic clock than men (Cohen’s d = 0.48). In women (but not men), slower epigenetic clock was associated 
with less symptoms of anxiety. In the brain, women (but not men) with slower epigenetic clock had greater GM 
volume in the cerebral cortex (brain size-corrected; R2 = 0.07). Lobe-specific analyses showed that in women 
(but not men), slower epigenetic clock was associated with greater GM volume in frontal lobe (R2 = 0.16), and 
that GM volume in frontal lobe mediated the relationship between the speed of epigenetic clock and anxiety trait 
(ab = 0.15, SE = 0.15, 95% CI [0.007; 0.369]). These findings were not replicated, however, in a community- 
based sample of adolescents (n = 129; 49% men; 12–19 years of age), possibly due to the different method of 
tissue collection (blood vs. saliva) or additional sources of variability in the cohort of adolescents (puberty stages, 
socioeconomic status, prenatal exposure to maternal smoking during pregnancy).   
1. Introduction 
Major depressive disorder (MDD) is the leading cause of years lost 
due to disability worldwide (Ustun et al., 2004). The lifetime prevalence 
of MDD is 16% (Kessler et al., 2005). It can develop at any age but the 
median age at onset is 32.5 years (America AaDAo, 2018). Diagnosis of 
MDD is highly correlated with anxiety symptoms and diagnosis 
(Jacobson and Newman, 2017). Still, the underlying mechanisms are not 
fully understood. 
One of the mechanistic theories of depression is the accelerated 
molecular aging (Sibille, 2013; Rozycka and Liguz-Lecznar, 2017). An 
unbiased investigation of genetic architecture with genome-wide asso-
ciation studies (GWAS) and gene expression in the human brain (tran-
scriptome) provided evidence for common biological pathways between 
depression and brain aging (Ding et al., 2015). Further evidence for 
accelerated aging in depression comes from research on telomere length 
reporting shorter telomeres in MDD patients than healthy controls 
(Schutte and Malouff, 2015; Ridout et al., 2016). Recently, additional 
evidence for the hypothesis of accelerated aging in depression came 
from epigenetic research. Using a novel index of epigenetic age cor-
rected for chronological age, post mortem studies of brain tissue as well 
as in vivo studies using blood tissue demonstrated higher epigenetic age 
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in MDD patients compared to controls, particularly those who experi-
enced higher level of trauma in childhood (Han et al., 2018). 
The current study focuses on epigenetic aging and tests the possi-
bility that it varies as a function of symptoms of anxiety in community- 
based cohorts of adolescents and young adults (with no clinical diag-
nosis of any major psychiatric disorders, as determined by self-report). 
This work is framed in the context of a DNA methylation-based 
“epigenetic clock”. In this framework, DNA methylation changes 
consistently throughout life and age-dependent alterations in DNA 
methylation, particularly the methylation status of 5’-cytosine-phos-
phate-guanine-3’ (CpG) sites, can be used to estimate one’s “methyl-
ation age”. There are two frequently used DNA methylation-based 
predictors of age: the Hannum’s (Hannum et al., 2013) and the Hor-
vath’s (Horvath, 2013) epigenetic clocks. The Hannum’s epigenetic 
clock is based on 71 CpG sites that estimate age based on blood-based 
DNA methylation (Hannum et al., 2013). The Horvath’s epigenetic 
clock is based on 353 CpG sites and can estimate age irrespective of the 
DNA source within the organism (Horvath, 2013). Given the two sources 
of DNA in this report (epithelial cells and blood cells), as well as the 
higher number of CpG sites, we have opted for using the Horvath 
method. The gap between DNA-methylation age and chronological age, 
often referred to as accelerated/de-accelerated aging (delta age), may 
reflect deviations from trajectories of “typical” (molecular) develop-
ment. Positive delta age (wherein DNA methylation age > chronological 
age) is largely believed to reflect latent pathological influences and 
could serve as a biomarker of deviations from normal developmental 
trajectories, age-associated health problems or psychiatric disease. 
At the level of the brain, normal developmental trajectory is char-
acterized by age-related decreases in gray matter (GM) volume, which 
start during childhood (Ducharme et al., 2016; Walhovd et al., 2017) 
and are thought to reflect a variety of neurobiological processes, such as 
age-related changes in spine density (Petanjek et al., 2011) and intra- 
cortical myelination (Miller et al., 2012). While the most significant 
remodeling of the cortex occurs by the late 20 s and early 30 s (Shaw 
et al., 2008; Giedd and Rapoport, 2010), cortical thinning and volume 
loss continue at slower pace also through middle age (Fjell et al., 2015) 
and accelerate again in later life (Pfefferbaum et al., 2013), possibly 
reflecting neurodegenerative processes (Fletcher et al., 2018). Although 
the early studies suggested that these developmental trajectories might 
be non-linear and lobe-specific (Giedd et al., 1999), larger and more 
recent studies demonstrated that cortical thickness follows a simple 
linear decline starting in most cortical regions by 5 years of age, and in 
all regions by 8 years of age (Ducharme et al., 2016). These linear tra-
jectories have been confirmed in other datasets and re-analyses (Wal-
hovd et al., 2017). 
These structural changes are paralleled by changes in cognitive 
control, emotion regulation and executive function, which are known to 
be impaired in depression and anxiety (Gotlib and Joormann, 2010; 
Joormann and Quinn, 2014; Joormann and Tanovic, 2015; Salthouse, 
2012). Further research focusing on GM structure suggested that 
depression, or vulnerability to its development, may be associated with a 
developmental trajectory reminiscent of premature aging. In particular, 
a longitudinal study by Luby et al demonstrated that early childhood 
depression was associated with faster age-dependent GM loss in pre-
frontal regions during adolescence (Frodl et al., 2008). A prospective 
longitudinal study of MDD patients and healthy controls revealed that 
patients who remitted during the 3-year period of the study had less 
decline in cortical as well as hippocampal volume than the non-remitted 
MDD patients (Frodl et al., 2008). A meta-analysis of voxel-based 
morphometry studies reported lower GM volumes in adults with MDD 
vs. healthy controls (Schmaal et al., 2017). A recent ENIGMA-based 
meta-analysis of structural alterations in MDD vs. healthy controls 
found lower cortical thickness across multiple regions in adult MDD 
patients but pointed out that, in adolescence, the MDD-related differ-
ences in thickness had a different spatial pattern (Schmaal et al., 2017). 
Within the current research, we aim to test whether the volume of 
cortical GM might mediate the relationship between faster epigenetic 
clock and symptoms of anxiety in young adults. To date, there has been 
only one study assessing an association between faster epigenetic clock 
and GM volume in two regions of interest – hippocampus and amygdala 
(Davis et al., 2017). In this report, faster epigenetic clock was associated 
with lower volumes of the hippocampus but not amygdala in 46 
adolescent girls, and faster epigenetic clock mediated the association 
between diurnal cortisol and left hippocampal volume (Davis et al., 
2017). Based on these findings, the authors concluded that faster 
epigenetic clock is associated with GM volume in region with 
glucocorticoid-induced atrophy but not other hypothalamo-pituitary- 
adrenal (HPA) axis subcortical regions responsive to stress (Davis 
et al., 2017). 
The current study investigated the relationships between the Hor-
vath’s epigenetic clock, volume of cortical GM and symptoms of anxiety 
in young adults participating in the European Longitudinal Study of 
Pregnancy and Childhood (ELSPAC), and its neuroimaging follow-up 
(VULDE). We also attempted to replicate our findings in an indepen-
dent cohort of adolescents participating in Saguenay Youth Study (SYS 
Pausova et al., 2017). We hypothesized that faster epigenetic clock will 
be associated with more symptoms of anxiety as well as less cortical GM 
in regions associated with anxiety and depression (Frodl et al., 2008; 
Schmaal et al., 2017; Davis et al., 2017; Pausova et al., 2017), in these 
two community-based samples, and that GM volume will be the medi-
ating factor linking the DNA methylation age and symptoms of anxiety. 
Given the sex-specific trajectories of brain development (Giedd et al., 
1999; Tanaka et al., 2012) and the higher prevalence of anxiety in 
women vs. men (Organization WH, 2002, 2016), we also hypothesized 
that these relationships might differ by sex. 
2. Materials and methods 
2.1. Study 1 – Young adults from ELSPAC/VULDE cohort 
2.1.1. Participants 
Participants included 88 young adults (53% men; 23–24 years of age; 
all of European ancestry) from the European Longitudinal Study of Preg-
nancy and Childhood (ELSPAC-CZ) (Prokhorskas et al., 1989; Piler et al., 
2017), a birth cohort born in the South Moravian Region of the Czech 
Republic between 1991 and 1992, who also participated in its neuro-
imaging follow-up Biomarkers and Underlying Mechanisms of Vulnerability 
to Depression (VULDE) at the Central European Institute of Technology, 
Masaryk University (CEITEC MU), and provided saliva sample for 
epigenetic analysis. The recruitment flow diagram is provided in 
Fig. S1.. Further characteristics of the sample are provided in Table S1. 
All participants provided written informed consent with participation in 
the VULDE study, including the agreement to merge data from VULDE 
with their historic data from ELSPAC-CZ. Ethical approval for the 
VULDE study was obtained from the ELSPAC Ethics Committee. 
2.1.2. DNA methylation 
DNA methylation was assessed with the Illumina EPIC platform. 
“Methylation age” was estimated as follows. First, R package ChAMP 
(Tian et al., 2017) was used to process the raw Illumina microarray data. 
Raw data were trimmed of: (i) probes with <3 beads in at least 5% of 
samples per probe, (ii) SNP-related probes, (iii) multi-hit probes, (iv) 
probes located in chromosomes X and Y. Beta mixture quantile 
normalization (BMIQ (Teschendorff et al., 2013) method was used to 
adjust the beta-values of type II design probes into a statistical distri-
bution characteristic of type I probes. Next, DNA methylation age was 
calculated using an epigenetic clock developed by Horvath (2013), 
which uses 353 CpG sites to estimate DNA methylation age. Since 20 of 
the 353 CpGs on the Horvath’s list were either not available on the EPIC 
microarray or did not pass quality control criteria, the DNA methylation 
age was calculated using 323 CpG probes. These calculations used the R 
software tutorial published in the original Horvath’s paper (Horvath, 
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2013). 
Next, we residualized the DNA methylation age estimates on the 
proportion of epithelial cells in each participant (the average proportion 
was 80% of epithelial and 20% of immune cells; SD = 13% in each 
group) and on the batch and saved the residuals from the analysis as the 
cell-corrected DNA methylation age. Finally, the delta age was defined 
as the difference between this cell-corrected DNA-methylation age and 
chronological age with positive values reflecting accelerated aging/ 
faster maturation and negative values reflecting decelerated aging/ 
slower maturation. 
2.1.3. MRI imaging 
T1-weighted images (TR = 2300 ms, TE = 2.34 ms, flip angle = 8◦, 
240 slices, resolution 1 × 1 × 1 mm) were acquired on a 3T Siemens 
Prisma MRI scanner on the same day as the saliva collection and pro-
cessed using Toronto Volumetric Pipeline to calculate the total volume 
of cortical gray matter (GM) and the volumes of GM in the four cerebral 
lobes. See Supplementary Methods for the exact procedures. 
2.1.4. Anxiety trait in young adulthood 
Anxiety trait in young adulthood was assessed using the Spielberg-
er’s State-Trait Anxiety Inventory (STAI) (Spielberger et al., 1983), a 
self-report questionnaire assessing anxiety trait (20questions) using a 4- 
point Likert scale. 
2.1.5. Statistical analyses 
All statistical analyses were done in JMP version 10.0.0 (SAS Insti-
tute Inc., Cary, NC). First, we used t-test to assess possible sex differences 
in the delta age (defined as the difference between cell-corrected DNA- 
methylation age and chronological age). Second, a full factorial general 
linear model (GLM) assessed the relationships between delta age, sex, 
and behavioral outcomes (anxiety trait). Current body mass index 
(BMI), smoking and alcohol use in the past 30 days were added as 
covariates. Next, we assessed the relationship between delta age, sex and 
absolute GM volume (corrected for brain size) and followed these 
findings with a full factorial GLM assessing the relationships between 
delta age, sex, GM volume and lobe. Again, BMI, smoking and alcohol 
use were added as covariates. Finally, a mediation analysis using boot-
strapping evaluated whether GM volume might mediate the relationship 
between delta age and the behavioral outcomes (anxiety trait). This 
analysis set-up reflects a framework in which the brain is considered as 
the intermediate phenotype that mediates the relationship between 
molecular processes and behavior. 
2.2. Study 2 – Adolescents from SYS 
2.2.1. Participants 
Participants included 129 adolescents (49% men; 12–19 years of 
age) from the Saguenay Youth Study (Pausova et al., 2017), a cohort 
recruited from population of the Saguenay Lac St Jean region of Quebec, 
Canada, who underwent structural MRI and provided blood sample for 
the epigenetic analyses. Further characteristics of the sample are pro-
vided in Table S2. All adolescents and their parents provided written 
informed assent and consent, respectively, with participation in the SYS 
study and ethical approval for the SYS study was obtained from the 
Research Ethics Committee of the Chicoutimi Hospital. 
2.2.2. DNA methylation 
DNA methylation was assessed using the Infinium Human Methyl-
ation 450 K Bead Chip (>485 000 CpGs) from blood, which included all 
the 353 CpGs present on the Horvath’s list. Remaining steps regarding 
the calculation of DNA methylation age were done as described in Study 
1 above. 
In order to correct for the cell proportions in blood, and other 
possible confounders known to be associated with DNA methylation 
(Suarez et al., 2018; Binder et al., 2018; Simpkin et al., 2016; Javed 
et al., 2016; Lee et al., 2015), we identified 5 principal components of 
the estimated cell type proportions (Houseman et al., 2012) and calcu-
lated the cell-corrected DNA methylation age by residualizing the DNA 
methylation age estimates on the 5 principal components of the esti-
mated cell type proportions and on batch. Finally, the delta age was 
defined as the difference between this cell-corrected DNA methylation 
age and chronological age with positive values reflecting accelerated 
aging/faster maturation and negative values reflecting decelerated 
aging/slower maturation. 
2.2.3. MRI imaging 
T1-weighted images (TR = 25 ms, TE = 5 ms, flip angle = 30◦, 
140–160 slices, resolution 1x1x1mm) were acquired on 1T Philips MRI 
scanner approximately 19 days before the blood collection (M = 19 
days, SD = 37.6). Toronto Volumetric Pipeline was used to calculate the 
total volume of cortical GM and the volumes of GM in the four cerebral 
lobes. The processing steps in the Toronto Volumetric Pipeline were the 
same as described in the Methods for Study 1. In addition, the total 
(lobar) GM volume as well as the individual lobar volumes were cor-
rected for chronological age. 
2.2.4. Anxiety in adolescence 
Anxiety in adolescence were assessed using the Diagnostic Interview 
Schedule for Children (DISC) Predictive Scales (DPS Lucas et al., 2001). 
2.2.5. Statistical analyses 
The statistical analyses were done in JMP version 10.0.0 (SAS 
Institute Inc., Cary, NC) and mirrored those described in Study 1. In 
addition to the covariates used also in the Study 1 (BMI, smoking in the 
past 30 days) the full factorial GLMs in Study 2 used also puberty stage 
and prenatal exposure to maternal cigarette smoking as covariates. 
3. Results 
3.1. Study 1 – Young adults from ELSPAC/VULDE cohort 
3.1.1. Sex differences in the delta age 
While the chronological age of all participants was 23–24 years, their 
delta age ranged from − 9 to +8 years (Fig. 1A). We observed sex dif-
ferences in the delta age (t(87) = − 2.24, p = 0.03; Cohen’s d = 0.48; 
Fig. 2A), with men having significantly higher delta age than women. 
These sex differences remained significant after the correction for 
covariates (BMI, smoking and alcohol use in the past 30 days): beta =
0.23, p = 0.05, Adj R2 = 0.07. 
3.1.2. Delta age and its relationship with anxiety trait 
Sex moderated the associations between delta age and anxiety trait 
(beta = − 0.30, p = 0.009; Fig. 3); this sex-by-delta age interaction was 
independent of all the covariates (BMI, smoking, alcohol use). Posthoc 
analyses revealed that, in women, delta age was positively associated 
with anxiety trait (beta = 0.63, p = 0.04, R2 = 0.15). This was not the 
case in men (p > 0.12). 
3.1.3. Delta age and its relationship with volume of cortical GM 
In the brain, sex moderated the association between delta age and 
brain-size corrected volume of cortical GM (beta = 0.27, p = 0.02; 
Fig. 4A); this sex-by = delta age interaction was independent of all the 
covariates (BMI, smoking, alcohol use). Posthoc analyses revealed that, 
in women, delta age was negatively associated with volume of cortical 
GM (beta = − 0.35, p = 0.04, AdjR2 = 0.07). This was not the case in men 
(p > 0.30). 
Further, a full-factorial GLM showed that delta age was associated 
with GM volume in sex- and lobe-specific manner (F(3,216) = 3.09, p =
0.03); post-hoc analyses revealed that higher delta age was associated 
with lower GM volume in the frontal lobe of women (beta = − 0.40, p =
0.02, AdjR2 = 0.16; Fig. 4B) but not men (beta = − 0.03, p = 0.89) and 
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this association was independent of all the covariates (BMI, smoking, 
alcohol use). There were no associations between delta age and GM 
volume in the other lobes. 
3.1.4. Does GM volume in the frontal lobe mediate the relationship between 
delta age and anxiety in women? 
A mediation analysis revealed that, in women GM volume in frontal 
lobe mediated the relationship between delta age and anxiety trait (ab =
0.15, SE = 0.15, 95% CI [0.007; 0.369]; Fig. 5). 
3.2. Study 2 – Adolescents from SYS 
3.2.1. Sex differences in the delta age 
While the chronological age of all participants was 12–19 years, their 
delta age ranged from − 6 to +6 years (Fig. 1B). Similarly to the ELSPAC/ 
VULDE cohort, we observed significant sex differences (men > women) 
in the delta age (t(127) = − 2.27, p = 0.034, Cohen’s d = 0.40; Fig. 2B), 
which remained significant also after the correction for puberty stage, 
BMI, smoking and prenatal exposure to maternal cigarette smoking 
(beta = 0.21, p = 0.03, AdjR2 = 0.06). 
3.2.2. Delta age and its relationship with anxiety 
We did not find any relationship between delta age and anxiety (beta 
= 0.05, p = 0.56) as measured by DISC (Lucas et al., 2001) or any in-
teractions between delta age and sex (beta = 0.03, p = 0.70). Correcting 
for the covariates (puberty stage, BMI, smoking, exposure to maternal 
cigarette smoking) did not change these results (delta age on anxiety: 
beta = 0.04, p = 0.64; delta age * sex on anxiety: beta = 0.06, p = 0.51). 
3.2.3. Delta age and its relationship with volume of cortical GM 
There was no association between delta age and the age- and brain- 
size corrected cortical GM volume (beta = 0.02, p = 0.80) or the age- 
and brain-size corrected GM volume in the frontal lobe (beta = 0.02, p =
0.82); there was no interaction between delta age and sex vis-à-vis age- 
and brain-size corrected GM volume (beta = − 0.06, p = 0.53) or GM 
volume in the frontal lobe (beta = 0.004, p = 0.97). These results did not 
change when correcting for puberty stage, BMI, smoking and prenatal 
exposure to maternal cigarette smoking (all p > 0.38). 
4. Discussion 
This study used structural MRI and epigenetics data from young 
Fig. 1. Delta age in young adulthood and adolescence. While the chronological age of all young adults from Study 1 was 23–24 years, their delta age ranged from − 9 
to +8 years (1A). The chronological age of all adolescents from Study 2 was 12–19 years and their delta age ranged from − 6 to +6 years (1B). 
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adults participating in the European Longitudinal Study of Pregnancy 
and Childhood (ELSPAC), and its neuroimaging follow-up (VULDE) to 
assess the relationships between epigenetic clock (Horvath, 2013); gray- 
matter volume of the cerebral cortex, and symptoms of anxiety. While all 
young adult participants were 23–24 years old at the time of saliva 
sampling, MRI and behavioral assessments, their delta age ranged from 
− 9 to +8 years. Young women had lower DNA-methylation age and 
slower epigenetic clock than young men. In young women (but not 
men), the speed of epigenetic clock was positively associated with-
symptoms of anxiety. In the brain, the speed of epigenetic clock in young 
women (but not men) was negatively associated with total volume of 
cortical GM (corrected for brain size). Lobe-specific analyses showed 
that in young women (but not men), the speed of epigenetic clock was 
negatively associated with GM volume in the frontal lobe and that the 
GM volume in the frontal lobe mediated the relationship between the 
epigenetic clock (delta age, defined as the difference between epigenetic 
and chronological age) and anxiety. We were not able to replicate these 
findings in a sample of adolescents from Saguenay Youth Study. 
The relatively wide range of delta age (− 9 to +8 years) in our sample 
of young adults (all 23–24 years old, all of European ancestry, born in 
the same region of Czech Republic) is most likely related to both genetic 
and environmental factors. Horvath (Horvath, 2013) demonstrated that 
the heritability of delta age is 100% in newborns and 39% in older 
subjects, which suggests that non-genetic factors become more relevant 
with age. In our sample, the mean delta age was negative, thus reflecting 
rather slower speed of the biological clock and slower (molecular) 
maturation. Since genes co-located with the 353 CpGs defining the DNA 
methylation age are enriched for cell death/survival, cellular growth/ 
proliferation, organismal/tissue development and cancer (Horvath, 
2013), we conclude that individuals with greater discrepancy between 
their chronological and epigenetic age experienced altered develop-
mental/aging processes, leading to slower or faster maturation of the 
brain. 
The sex differences in delta age found in young adults are consistent 
with the relatively higher epigenetic aging rate found in saliva as well as 
blood and brain tissue of men vs. women in previous research (Horvath 
et al., 2016). They are also consistent with the larger lifespan in women 
vs. men (Case and Paxson, 2005; Oksuzyan et al., 2008). Since Suarez et 
al (Suarez et al., 2018) reported a relationship between higher delta age 
and higher pubertal stage of breast/genital development, Binder et al 
(Binder et al., 2018) reported a relationship between higher delta age 
and earlier puberty, Levine et al (Levine et al., 2016) demonstrated that 
menopause accelerates the epigenetic clock and Horvath (Horvath, 
2013) demonstrated an association between higher delta age and 
endocrine system disorders and reproductive system disease, it might be 
that sex hormones and sex-hormone related genes might contribute to 
the sex differences in delta age. 
The positive relationship between the speed of epigenetic clock and 
symptoms of anxiety in young adult women is consistent with Suarez 
et al. (2018) who found a relationship between accelerated aging and 
internalizing and affective problems in adolescents. The fact that we 
observed these relationships between the delta age and anxiety only in 
women fits with the generally higher risk of anxiety in adult women than 
men (Organization WH, 2002, 2016), and is also consistent with Davis 
et al. (2017)) who found a relationship between higher accelerated 
aging and higher diurnal cortisol and lower hippocampal volume in 
adolescent females. 
The negative relationship between the speed of epigenetic clock and 
GM is consistent with the normal age-related trajectories of cortical 
volume (Giedd et al., 1999; Wierenga et al., 2014). The fact that these 
effects reached largest effects in the frontal lobe of young adult women, 
and that it mediated the relationship between delta age and anxiety 
symptoms, might reflect the sex-specific trajectories of brain develop-
ment (Giedd et al., 1999; Tanaka et al., 2012). 
Since prior work suggests that higher levels of trait anxiety are 
associated with future vulnerability to depression (Wang et al., 2019), 
particularly in the context of stress (Weger and Sandi, 2018), we inter-
pret these effects as reflecting probable risk for subsequent psychopa-
thology. Further prospective longitudinal studies are planned in order to 
test this conjecture in the current cohort. Longitudinal data would also 
allow us to explore the directionality of the effects reported by our 
mediation model. 
Given the relatively small size of our discovery (ELSPAC/VULDE) 
sample (n = 88), we attempted to replicate these findings in an inde-
pendent cohort of adolescents (n = 129; 12–19 years old). While the 
delta age in adolescents ranged from − 6 to +6 years similarly to the 
Fig. 2. Sex differences delta age. In young adulthood, delta age was higher in 
men than women (t(87) = − 2.24, p = 0.03; Cohen’s d = 0.48; 2A) and this effect 
survived also the correction for BMI, smoking and alcohol use in the past 30 
days. The delta age was also higher in the male vs. female adolescents (t(127) =
− 2.27, p = 0.034, Cohen’s d = 0.40; 2B) and this effect also survived the 
correction for all covariates (BMI, puberty stage, smoking and prenatal expo-
sure to maternal cigarette smoking (beta = 0.21, p = 0.03, AdjR2 = 0.06). 
Fig. 3. In young adult women, higher delta age was associated with more 
anxiety trait (beta = 0.63, p = 0.04, R2 = 0.15). 
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ELSPAC/VULDE cohort (ranging from − 9 to +8 years), and while the 
mean delta age was also slightly negative, suggesting a rather slower 
maturation, particularly in adolescent females whose delta age was 
more negative than in males (Cohen’s d = 0.40), we did not find any 
relationship between adolescents’ delta age and anxiety (measured by 
DISC (Lucas et al., 2001) or the GM volume (age and brain size- 
corrected). This lack of replication in the adolescents might be related 
to the different method of tissue collection for epigenetic analysis (blood 
in adolescents vs. saliva in young adults) or additional sources of vari-
ability in the cohort of adolescents (e.g., puberty stages (Suarez et al., 
2018), socioeconomic status (Simons et al., 2016; Hughes et al., 2018), 
prenatal exposure to maternal smoking during pregnancy (Lee et al., 
2015) known to be associated with epigenetic aging). It is also possible, 
that the effects of delta age on the GM volume and symptoms of anxiety 
might fully manifest only in young adulthood. In fact, Schmaal et al. 
(2017) pointed out that MDD-related structural brain abnormalities 
differ between adults and adolescents and suggested that greater cortical 
thinning might be more pronounced in adult-onset MDD patients. In 
addition, previous research in MDD adolescents reported lower (Boes 
et al., 2008; Fallucca et al., 2011; Shad et al., 2012), higher (Fallucca 
et al., 2011; Reynolds et al., 2014), or no differences (Whittle et al., 
Fig. 4. In young adult women, higher delta age was associated with less brain size-corrected gray matter volume. These effects were significant for the total (lobar) 
gray matter volume (beta = − 0.35, p = 0.04, AdjR2 = 0.07; 4A) and particularly in the frontal lobe (beta = − 0.40, p = 0.02, AdjR2 = 0.16; 4B). 
Fig. 5. In young adult women, GM volume in frontal lobe mediated the rela-
tionship between delta age and anxiety trait (ab = 0.15, SE = 0.15, 95% CI 
[0.007; 0.369]). Standardized coefficients are provided. 
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2014) in cortical thickness. It is also possible that the result in the 
ELSPAC/VULDE cohort is due to chance and not replicable. Thus, future 
research should try to replicate the ELSPAC/VULDE findings in a larger 
sample of young adults and use saliva for the epigenetic analyses. Future 
research might also use larger datasets to explore the impact of epige-
netic clock on subcortical volumes previously associated with anxiety 
and depression. 
5. Conclusions 
Overall, we conclude that in young adult women, the speed of 
epigenetic clock is negatively associated with total volume of cortical 
GM (corrected for brain size), particularly in the frontal lobe, and that 
GM volume in the frontal lobe mediates the relationship between the 
speed of epigenetic clock and anxiety trait. Since our imaging studies 
focused on healthy and relatively highly functioning young adults, 
where the variability of anxiety symptoms does not span the full range of 
severity, future studies should aim to recruit individuals with clinically 
diagnosed mental illness to confirm the generalizability and potential 
clinical relevance of the current findings. Further, while the ELSPAC/ 
VULDE cohort was followed-up prospectively, our DNA-methylation age 
as well as the imaging data were cross-sectional. Future research on DNA 
methylation age should use longitudinal data to determine the stability 
and behavioral relevance of the effects of epigenetic age in time. Such 
future research should also determine whether individuals with higher 
delta age experience an earlier onset but then the same speed (and thus 
the same slope) of aging-related processes or whether they experience 
faster (and thus a steeper slope) aging-related processes throughout 
their lives. 
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